Your browser doesn't support javascript.
The continuing discovery on the evidence for RNA editing in SARS-CoV-2.
Pu, Xiaoxin; Xu, Qinwei; Wang, Jinxiang; Liu, Baoyi.
  • Pu X; Department of Respiratory and Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College Medicine, Shandong University, Qingdao, China.
  • Xu Q; Department of Respiratory and Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College Medicine, Shandong University, Qingdao, China.
  • Wang J; Department of Respiratory and Critical Care Medicine, Qilu Hospital (Qingdao), Cheeloo College Medicine, Shandong University, Qingdao, China.
  • Liu B; Department of Respiratory and Critical Care Medicine, Qilu Hospital, Cheeloo College Medicine, Shandong University, Jinan, China.
RNA Biol ; 20(1): 219-222, 2023 01.
Article in English | MEDLINE | ID: covidwho-2325666
ABSTRACT
Recent studies have presented strong evidence that C-to-U RNA editing is the driving force that fuels severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution. The findings finally ended the long-term debate on the evolutionary driving force behind SARS-CoV-2 evolution. Here, we would first acknowledge the breakthroughs made by the recent works, such as using the global SARS-CoV-2 data to demonstrate the major mutation source of this virus. Meanwhile, we would raise a few concerns on the accuracy of their interpretation on C-to-U RNA editing. By re-analysing the SARS-CoV-2 population data, we found that the editing frequency on C-to-U sites did not perfectly correlate with the binding motif of the editing enzyme APOBEC, suggesting that there might be false-positive sites among the C-to-U mutations or the original data did not fully represent the novel mutation rate. We hope our work could help people understand the molecular basis underlying SARS-CoV-2 mutation and also be useful to guide future studies on SARS-CoV-2 evolution.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: RNA Biol Journal subject: Molecular Biology Year: 2023 Document Type: Article Affiliation country: 15476286.2023.2214437

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: RNA Biol Journal subject: Molecular Biology Year: 2023 Document Type: Article Affiliation country: 15476286.2023.2214437